Cargando…

Predictors of functioning at clinical high-risk for psychosis

INTRODUCTION: In addition to the psychosis onset, patients at clinical high-risk (CHR) show a decrease of functioning. This may not be related to the degree and persistence of the attenuated positive symptom (APS). Other clinical factors also predict the level of remission. OBJECTIVES: Revealing the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Omelchenko, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567047/ http://dx.doi.org/10.1192/j.eurpsy.2022.304

Ejemplares similares

Treatment of the depressive patients at clinical high-risk for psychosis
por: Omelchenko, M.
Publicado: (2022)

Premorbid of depressive youth at clinical high-risk for psychosis
por: Omelchenko, M.
Publicado: (2022)

Attenuated positive and negative symptoms in patients at clinical high-risk for psychosis
por: Omelchenko, M.
Publicado: (2022)

Duration of therapy and treatment compliance of depressive patients at clinical high-risk for psychosis
por: Omelchenko, M.
Publicado: (2022)

5-years follow-up of patients with the clinical high-risk state for psychosi
por: Kaleda, V., et al.
Publicado: (2021)

Brain functional connectivity and local coherence in non-converters with clinical high risk for psychosis
por: Panikratova, Y., et al.
Publicado: (2023)

Correlations of thought disorders with attenuated positive symptoms at clinical high-risk state for psychosis
por: Kaleda, V., et al.
Publicado: (2023)

Increased and decreased cortical thickness and unaltered amygdala nuclei in patients at clinical-high risk of psychosis
por: Tomyshev, A. S., et al.
Publicado: (2023)

Neurocognitive Functioning of Adolescents with Clinical High Risk for Psychosis, other Psychiatric Symptoms, and Psychosis
por: Orlandi, M., et al.
Publicado: (2022)

Multimodal magnetic resonance spectroscopy and surface-based morphometry study of individuals at ultra-high-risk for psychosis
por: Tomyshev, A., et al.
Publicado: (2021)

Neurocognitive function in patients at high risk of schizophrenia with positive thought disorders
por: Fateev, I., et al.
Publicado: (2021)

26.4 LANGUAGE DISTURBANCE AS A PREDICTOR OF PSYCHOSIS ONSET IN YOUTH AT ENHANCED CLINICAL RISK
por: Corcoran, Cheryl, et al.
Publicado: (2018)

Transition to Psychosis in Individuals at Clinical High Risk: Meta-analysis
por: Salazar De Pablo, G., et al.
Publicado: (2023)

F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
por: Foss-Feig, Jennifer, et al.
Publicado: (2018)

PM459. Brain Network Characteristics of Individuals at Clinical High Risk for Psychosis in between Normality and Psychosis: A Combined Structural and Functional Imaging Study
por: Choi, Soo-Hee, et al.
Publicado: (2016)

Pharmacotherapy of high-risk population for developing psychosis
por: Mohr, P.
Publicado: (2023)

Clinical high-risk criteria of psychosis in 8- to 17-year-old community subjects and inpatients not suspected to develop psychosis: not pluripotential or transdiagnostic
por: Schultze-Lutter, F., et al.
Publicado: (2022)

S105. VALIDATING THE PREDICTIVE ACCURACY OF THE NAPLS-2 PSYCHOSIS RISK CALCULATOR IN A CLINICAL HIGH-RISK SAMPLE FROM THE SHARP (SHANGHAI AT RISK FOR PSYCHOSIS) PROGRAM
por: Zhang, TianHong, et al.
Publicado: (2018)

S214. USING ONLINE-SCREENING TO DETECT PARTICIPANTS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: McDonald, Mhairi, et al.
Publicado: (2018)

F36. SELF-ESTEEM AND SYMPTOMS IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Benavides, Caridad, et al.
Publicado: (2018)

T135. NEIGHBORHOOD-LEVEL PREDICTORS OF AGE AT ONSET AND DURATION OF UNTREATED PSYCHOSIS IN FIRST-EPISODE PSYCHOSIS
por: Ku, Benson, et al.
Publicado: (2018)

21.4 BASELINE CLINICAL AND BIOLOGICAL VARIABLES PREDICTING 1 YEAR OUTCOME OF SUBJECTS AT CLINICAL HIGH RISK OF PSYCHOSIS: INSIGHT FROM SHANGHAI AT RISK FOR PSYCHOSIS (SHARP) PROGRAM
por: Zhang, TianHong, et al.
Publicado: (2018)

The Investigation of Cognitive Functions and Clinical High Risk Status for Psychosis in First-Degree Relatives of Patients with Substance Induced Psychotic Disorder
por: Çukurova, M., et al.
Publicado: (2022)

T207. A REVIEW OF PREDICTORS OF RESPONSIVENESS TO CBT FOR PSYCHOSIS
por: de Sousa, Ana Elisa Farias, et al.
Publicado: (2018)

O10.5. ABNORMAL MODULAR ORGANIZATION OF THE FUNCTIONAL CONNECTOME PREDICTS CONVERSION TO PSYCHOSIS IN CLINICAL HIGH-RISK YOUTH
por: Collin, Guusje, et al.
Publicado: (2018)

26.2 CORTICAL STRESS REGULATION IS DISRUPTED IN SCHIZOPHRENIA BUT NOT IN CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Mizrahi, Romina, et al.
Publicado: (2018)

39.1 DNA METHYLATION OF IMMUNE CELLS IN PERSONS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Perkins, Diana, et al.
Publicado: (2018)

High risk of psychosis, condition or diagnosis? About a case.
por: Maria Del Carmen, M. L., et al.
Publicado: (2023)

T62. COMPARISON OF NEUROCOGNITIVE FUNCTIONS IN FIRST-EPISODE SCHIZOPHRENIA PATIENTS, NON-PSYCHOTIC SIBLINGS, AND INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Chu, On Ki, et al.
Publicado: (2018)

O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT
por: Cullen, Alexis, et al.
Publicado: (2018)

Immunotherapy and psychosis: It there a risk?
por: Barbosa, D., et al.
Publicado: (2021)

Psychosis: Risk Factors and Prognosis
por: Fernández Lozano, M., et al.
Publicado: (2022)

F252. SERVICE PROVISION FOR ULTRA-HIGH RISK FOR PSYCHOSIS: IMPLEMENTATION OF CLINICAL GUIDELINES IN ENGLAND
por: Stain, Helen, et al.
Publicado: (2018)

F153. NEUROMAGNETIC MISMATCH NEGATIVITY IN CLINICAL HIGH RISK AND FIRST-EPISODE PSYCHOSIS INDIVIDUALS
por: Mikanmaa, Emmi, et al.
Publicado: (2018)

PM466. Neuroanatomical implications of concomitant mood disorders in subjects at clinical high risk for psychosis
por: Kwak, Yoo Bin, et al.
Publicado: (2016)

PM504. Theory of Mind in Clinical high risk as trait marker of conversion to psychosis: review
por: Suh, Jee-Hyung, et al.
Publicado: (2016)

F32. DIFFERENCES BETWEEN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS WHO DO NOT TRANSITION TO PSYCHOSIS: THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (NAPLS-2)
por: Santesteban-Echarri, Olga, et al.
Publicado: (2018)

O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS
por: Woodberry, Kristen, et al.
Publicado: (2018)

T104. ASSESSING THE UTILITY OF COPULA FUNCTIONS FOR RISK PREDICTION OF PSYCHOSIS
por: Zhang, Landan, et al.
Publicado: (2018)

F163. STRUCTURAL AND FUNCTIONAL ALTERATIONS IN THE BRAIN DURING WORKING MEMORY IN MEDICATION-NAïVE PATIENTS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Brønnick, Kolbjørn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7q25o3oka61c3mikhtc1rhjkv7